Importantly, this leads to a MYC-dependent activation of mTOR, preventing autophagy and promoting tumorigenesis and metastasis.203 On the same line, MYC activity was also associated to metabolic adaptation after inhibition of eIF4E and mTOR pathways in KRAS-driven CRC. The gene discussed is KRAS; the disease is colorectal carcinoma.